MC38-hB7H3

Export PDF

Strain Information

Cell Line

MC38-Cd276em1(hB7H3)/Smoc

Cat. NO.

NM-S13-TM06

Model Description

The endogenous mouse Cd276(also known as B7h3)  gene was replaced by human B7H3 gene. 

Strain State

Validation of tumorigenic capacity completed

Validation Data

778659397ae5292b80887886442f3ab.png

Figure 1. hB7H3 expression in wild-type MC38 and MC38-hB7H3 cell lines.

image.png

Figure 2. Tumor growth curve of MC38-hB7H3 syngeneic model (n=5).

image.png

Figure 3. Body weight change of MC38-hB7H3 syngeneic model (n=5).

061cedf65e4be2c1f62889b585475f7.png

Figure 4. The expression of hB7H3 in humanized modified tumors by FACS.


Related Strain(s)

MC38-hCD47-hCLDN18.2-hB7H3
Cell Line：

MC38-hCD47-hCLDN18.2-hB7H3

Cat. NO.：NM-S13-TM71

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more